Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

FDA extends reproxalap review to March 2026 after Aldeyra submits major amendment

Aldeyra Therapeutics (NASDAQ:ALDX) said the U.S. Food and Drug Administration has extended the PDUFA target action date for its reproxalap New Drug Application (NDA) for dry eye disease to March 16, 2026, adding roughly three months to the original timeline.

Leia mais: FDA extends reproxalap review to March 2026 after Aldeyra submits major amendment
Grafa
Energy

Kyivstar makes first renewables investment with acquisition of 12.9 MW solar facility in Ukraine

VEON (NASDAQ:VEON) said its Ukrainian subsidiary Kyivstar has acquired 100% of LLC SUNVIN 11, securing 12.9 megawatts of solar generation capacity as the telecom operator continues investing in energy resilience amid ongoing national infrastructure challenges.

Leia mais: Kyivstar makes first renewables investment with acquisition of 12.9 MW solar facility in Ukraine
Grafa

Hooker Furnishings Sells Pulaski and Samuel Lawrence Brands for $6.1 Million

Hooker Furnishings Corp. (NASDAQ:HOFT) said it completed the sale of its Pulaski Furniture and Samuel Lawrence Furniture casegoods brands to Magnussen Home Furnishings for approximately $6.1 million, part of an ongoing effort to narrow its portfolio and refocus on higher-margin opportunities.


Leia mais: Hooker Furnishings Sells Pulaski and Samuel Lawrence Brands for $6.1 Million
Grafa
Health

Greenwich LifeSciences’ Vaccine Shows 80% Recurrence Reduction in FLAMINGO-01

Greenwich LifeSciences (NASDAQ:GLSI) announced an approximately 80% reduction in recurrence rates from a preliminary analysis of the 250-patient open-label arm of its Phase 3 FLAMINGO-01 breast cancer immunotherapy trial, GLSI-100.

Leia mais: Greenwich LifeSciences’ Vaccine Shows 80% Recurrence Reduction in FLAMINGO-01